GMAB
Genmab A/s
$20.47
Earnings Summary
Revenue | $5540Mn |
Net Profits | $1266Mn |
Net Profit Margins | 22.85% |
Highlights
Genmab A/s’s revenue jumped 16.78% since last year same period to $5540Mn in the Q3 2024. On a quarterly growth basis, Genmab A/s has generated 2.55% jump in its revenue since last 3-months.
Genmab A/s’s net profit fell -40.54% since last year same period to $1266Mn in the Q3 2024. On a quarterly growth basis, Genmab A/s has generated -10.09% fall in its net profits since last 3-months.
Genmab A/s’s net profit margin fell -49.08% since last year same period to 22.85% in the Q3 2024. On a quarterly growth basis, Genmab A/s has generated -12.32% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Genmab A/s post its latest quarter earnings
EPS Estimate Current Quarter | 0.35 |
EPS Estimate Current Year | 0.35 |
Highlights
Genmab A/s’s earning per share (EPS) estimates for the current quarter stand at 0.35 - a 6.06% jump from last quarter’s estimates.
Genmab A/s’s earning per share (EPS) estimates for the current year stand at 0.35.
Key Ratios
Key ratios of the Genmab A/s post its Q3 2024 earnings
Earning Per Share (EPS) | 0.29 |
Highlights
Genmab A/s’s earning per share (EPS) fell -38.3% since last year same period to 0.29 in the Q3 2024. This indicates that the Genmab A/s has generated -38.3% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-11-06 | 0.35 | 0.29 | -17.14% |
2024-08-08 | 0.33 | 0.31 | -6.06% |
2024-05-02 | 0.14 | 0.29 | 107.14% |
₹0 US Stocks a/c Opening Fee